Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Exenatide and rare adverse events.

× No keyword cloud information.

23 in total

1. Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents.

Authors: Krystyna Tatarkiewicz; Pamela A Smith; Emmanuel J Sablan; Clara J Polizzi; Donald E Aumann; Christiane Villescaz; Diane M Hargrove; Bronislava R Gedulin; Melissa G W Lu; Lisa Adams; Tina Whisenant; Denis Roy; David G Parkes
Journal: Am J Physiol Endocrinol Metab Date: 2010-10-05 Impact factor: 4.310

2. Collateral damage: the conundrum of drug safety.

Authors: E A M Gale
Journal: Diabetologia Date: 2009-10 Impact factor: 10.122

Review 3. Advances in pharmacologic therapies for type 2 diabetes.

Authors: Linde M Morsink; Mark M Smits; Michaela Diamant
Journal: Curr Atheroscler Rep Date: 2013-02 Impact factor: 5.113

Review 4. Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents.

Authors: Baptist Gallwitz
Journal: Drugs Date: 2011-09-10 Impact factor: 9.546

Review 5. Use of glucagon-like peptide-1 agonists to improve islet graft performance.

Authors: Yong Wang; Meirigeng Qi; James J McGarrigle; Brian Rady; Maureen E Davis; Pilar Vaca; Jose Oberholzer
Journal: Curr Diab Rep Date: 2013-10 Impact factor: 4.810

Review 6. Benefit-risk assessment of exenatide in the therapy of type 2 diabetes mellitus.

Authors: Baptist Gallwitz
Journal: Drug Saf Date: 2010-02-01 Impact factor: 5.606

Review 7. The evolving place of incretin-based therapies in type 2 diabetes.

Authors: Baptist Gallwitz
Journal: Pediatr Nephrol Date: 2010-02-04 Impact factor: 3.714

Review 8. Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.

Authors: Cassandra Koole; Emilia E Savage; Arthur Christopoulos; Laurence J Miller; Patrick M Sexton; Denise Wootten
Journal: Mol Endocrinol Date: 2013-07-17

9. Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?

Authors: P C Butler; A V Matveyenko; S Dry; A Bhushan; R Elashoff
Journal: Diabetologia Date: 2009-11-06 Impact factor: 10.122

10. GLP-1-based therapy for diabetes: what you do not know can hurt you.

Authors: Peter C Butler; Sarah Dry; Robert Elashoff
Journal: Diabetes Care Date: 2010-02 Impact factor: 19.112